LCDX (Caliber Imaging & Diagnostics) Cash-to-Debt: 0.05 (As of Mar. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Caliber Imaging & Diagnostics Cash-to-Debt?

Caliber Imaging & Diagnostics LCDX Cash-to-Debt is 0.05 as of Mar. 2014.

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Caliber Imaging & Diagnostics's cash to debt ratio for the quarter that ended in Mar. 2014 was 0.05.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Caliber Imaging & Diagnostics couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2014.

The historical rank and industry rank for Caliber Imaging & Diagnostics's Cash-to-Debt or its related term are showing as below:

LCDX's Cash-to-Debt is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.63
* Ranked among companies with meaningful Cash-to-Debt only.

Caliber Imaging & Diagnostics  (OTCPK:LCDX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Caliber Imaging & Diagnostics Cash-to-Debt Related Terms


Caliber Imaging & Diagnostics Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for Caliber Imaging & Diagnostics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Caliber Imaging & Diagnostics Cash-to-Debt Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Cash-to-Debt
0.01 0.14 1.33 0.13 0.07

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 71.31 98.75 0.07 0.05

LCDX vs VICA, CRVW, RSLS: Cash-to-Debt Comparison

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliber Imaging & Diagnostics Cash-to-Debt vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's Cash-to-Debt falls into.



Caliber Imaging & Diagnostics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Caliber Imaging & Diagnostics's Cash to Debt Ratio for the fiscal year that ended in Dec. 2013 is calculated as:

Caliber Imaging & Diagnostics's Cash to Debt Ratio for the quarter that ended in Mar. 2014 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash-to-Debt →
What does a Cash-to-Debt of 0.05 mean?
Caliber Imaging & Diagnostics (LCDX) has a Cash-to-Debt of 0.05 as of Mar. 2014.
Is Caliber Imaging & Diagnostics' Cash-to-Debt too high?
Caliber Imaging & Diagnostics' current Cash-to-Debt is 0.05. The Medical Devices & Instruments industry median Cash-to-Debt is 1.63. Caliber Imaging & Diagnostics' value of 0.05 is 96.9% below this industry median.
How does Caliber Imaging & Diagnostics' Cash-to-Debt compare to VICA and CRVW?
Caliber Imaging & Diagnostics' Cash-to-Debt of 0.05 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash-to-Debt is 1.63. Caliber Imaging & Diagnostics' value of 0.05 is 96.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.63, based on 844 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Caliber Imaging & Diagnostics's current Cash-to-Debt of 0.05 is 96.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caliber Imaging & Diagnostics's current Cash-to-Debt is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliber Imaging & Diagnostics stock overvalued right now?
Caliber Imaging & Diagnostics (LCDX) has a current Cash-to-Debt of 0.05. The current Cash-to-Debt is 0.05 and 96.9% below the Medical Devices & Instruments industry median of 1.63. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Caliber Imaging & Diagnostics (LCDX), the current Cash-to-Debt is 0.05 as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caliber Imaging & Diagnostics Business Description

Address 50 Methodist Hill Drive, Suite 1000, Rochester, NY, USA, 14623
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.